Abbott (ABT) Reports Q2 Earnings: What Key Metrics Have to Say
The reported revenue represents a surprise of +0.63% over the Zacks Consensus Estimate of $11.07 billion. With the consensus EPS estimate being $1.25, the EPS surprise was +0.8%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Abbott performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Net sales- Diagnostics- U.S.: $811 million versus the five-analyst average estimate of $832.19 million. The reported number represents a year-over-year change of -0.1%.
Net sales- Nutrition- International: $1.26 billion versus the five-analyst average estimate of $1.26 billion. The reported number represents a year-over-year change of +3.1%.
Net sales- Nutrition- U.S.: $957 million versus the five-analyst average estimate of $985.2 million. The reported number represents a year-over-year change of +2.6%.
Net sales- Diagnostics- International: $1.36 billion versus the five-analyst average estimate of $1.38 billion. The reported number represents a year-over-year change of -1.5%.
Net sales- Established Pharmaceuticals: $1.38 billion versus $1.37 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +6.9% change.
Net sales- Diagnostics: $2.17 billion versus the six-analyst average estimate of $2.22 billion. The reported number represents a year-over-year change of -1%.
Net sales- Medical Devices- Diabetes Care: $1.98 billion versus $1.94 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +20.2% change.
Net sales- Nutrition: $2.21 billion versus $2.24 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +2.9% change.
Net sales- Medical Devices- Structural Heart- Total: $636 million compared to the $643.65 million average estimate based on five analysts. The reported number represents a change of +12.8% year over year.
Net sales- Medical Devices- Heart Failure- Total: $368 million versus $350.99 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +14.6% change.
Net sales- Medical Devices- Electrophysiology- Total: $700 million versus the five-analyst average estimate of $671.21 million. The reported number represents a year-over-year change of +11.6%.
Net sales- Medical Devices- Vascular- Total: $757 million versus $754.03 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +4.6% change.
View all Key Company Metrics for Abbott here>>>
Shares of Abbott have returned -0.5% over the past month versus the Zacks S&P 500 composite's +4.2% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Abbott Laboratories (ABT) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Wayfair Poised For Q2 Sales Beat On Strong Inventory, Vendor Promotions
Wayfair (NYSE:W) is gearing up to release its second-quarter earnings before the market opens on August 4, with expectations of surpassing Street estimates for both sales and profitability. On Monday, Bank of America Securities analyst Curtis Nagle reiterated a Neutral rating on Wayfair, setting a price forecast of $60. Nagle's projection of $3.15 billion in second-quarter sales surpasses the Street's consensus of $3.12 billion. This more bullish outlook is attributed to stronger-than-expected industry trends, increased inventory availability driven by higher utilization of Wayfair's CastleGate system, and effective vendor-funded analyst's EBITDA estimate of $153 million also exceeds the Street's $146 million, fueled by expectations of higher gross profit dollars due to greater flow-through and leverage from Selling, Operations, Technology, General & Administrative expenses, particularly from a right-sizing of the company's tech headcount. Supporting these positive trends, Bank of America's aggregated credit and debit card data indicated a slight improvement in online furniture spending, which declined by 0.8% year-over-year in the second quarter, compared to a 1.6% decline in the first quarter. Nagle suggests that these improving trends could signify a pull-forward in demand and increased promotional spending, although this might potentially come at the expense of industry sales later in the year. He further noted that accelerating web and app trends suggest Wayfair is continuing to gain market share, driven by better product availability and vendor-funded promotions. Consequently, Nagle raised his second-quarter sales estimate by 1% to $3.15 billion and his EBITDA estimate by 2%. Looking ahead to the third quarter, Nagle also increased his sales estimate by 1% to $2.86 billion, which aligns closely with the Street's estimate of $2.87 billion. This adjustment reflects the better-than-expected performance of consumer spending and the broader furnishings category. Furthermore, concerns regarding tariffs appear to be easing following Vietnam's trade deal, despite an August 1 deadline. The extended Black Friday in July event also indicates a healthy supply on the site, likely as vendors increasingly leverage CastleGate. Nagle sees this event as an additional opportunity for Wayfair to drive incremental sales. However, he maintained his fourth-quarter estimates, primarily due to tougher year-over-year comparisons. While tariff concerns are abating, they remain a significant point of discussion for Wayfair. As such, topics on the upcoming earnings call are likely to revolve around the potential impact of tariffs on second-half 2025 trends and how vendors are navigating these challenges, particularly through CastleGate, vendor-funded promotions, and renegotiations. Nagle observed that the current share price already reflects the potential upside from easing tariffs and healthy supply trends. Price Action: Wayfair shares are trading lower by 1.51% to $55.59 at last check Monday. Read Next:Image via Shutterstock Latest Ratings for W Date Firm Action From To Feb 2022 Credit Suisse Maintains Outperform Feb 2022 RBC Capital Maintains Sector Perform Feb 2022 Needham Maintains Buy View More Analyst Ratings for W View the Latest Analyst Ratings Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? WAYFAIR (W): Free Stock Analysis Report This article Wayfair Poised For Q2 Sales Beat On Strong Inventory, Vendor Promotions originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio
Yahoo
3 minutes ago
- Yahoo
Embrace the chaos: A Morgan Stanley derivatives exec on life at the desk
Sales and trading desks have thrived amid market volatility this year, boosting bank revenues. To decode what industry upstarts need to succeed, BI spoke to a top exec at Morgan Stanley. Iliana Bouzali, a global derivatives head, shared her advice and experience on the trading floor. When you think about Wall Street, you usually think about M&A — but with dealmaking in the slumps, big banks' sales and trading desks have become the stars of the show. In the first half of the year, several major banks reported record-breaking revenues from helping institutional clients, such as hedge funds and pension funds, trade stocks, bonds, and derivatives. A volatile 2025 market has brought more price swings, more trading opportunities, and more client activity than ever before. With all eyes on this booming business, Business Insider set out to shine a spotlight on Wall Street's sales and trading business. What's life like at the desk? What does it take to thrive in this fast-paced job? And what should young people aspiring to work in sell-side sales and trading know? For answers, we turned to Iliana Bouzali, global head of derivatives distribution and structuring for Morgan Stanley. She started her career as an intern at Morgan Stanley in 2003. She was pursuing an economics degree at Yale when she fell in love with the trading floor and never looked back. "The energy of a trading floor is like nothing else. It's not for everyone, but if you like it, you love it," she told Business Insider. "It's a very flat architecture, there's no hierarchy. If you have something useful to say, you say it. If there's a problem to solve, it doesn't matter what your title is, you solve the problem. And it can be very infectious, so I was hooked." Whether you're pitching clients on the products they need to grow and protect their portfolios (sales) or executing on those orders (trading), Wall Street trading floors are known as fast-paced, high-intensity environments where people thrive on the adrenaline and competition of following the market. To succeed, she said, you must embrace the chaos. "Life, markets, clients — can be complicated. It will be chaotic at times," she said, adding, "The best young hires don't panic, they adjust under pressure." Here is Bouzali's advice for interns and industry upstarts after 21 years rising in the ranks on the trading floor of one of Wall Street's most competitive banks. Embrace insecurity rather than avoid it Bouzali said she often tells young hires to use their inevitable feelings of fear and insecurity as motivation to work hard instead of faking confidence or know-how. "I always like telling our incoming interns: You will be insecure, it's a fact of life," she said. "Embrace it and let those insecurities, your fears, become a driving force. Use them instead of pretending that they're not there." Bouzali, for example, admitted to feeling both excited and terrified during her first summer on the trading floor, and was worried she didn't know enough about finance. "It's important to not compare yourself to peers and start competing against a more honest metric — the version of yourself that plays it safe." Learn to deal with "opacity" One of Bouzali's earliest lessons was learning not to expect the structure and direction she was used to at university, where the path to success is clearly laid out in syllabi and measured via homework and tests. "A trading floor is particularly opaque, and that ambiguity is a feature, it's not a bug," she said. If that's confusing, it's meant to be, Bouzali said. "It's something that I try to convey to our interns early on," she said, adding, "You will not always be handed tasks or told exactly what to do and how to do it." Opacity is not a signal to wait, but to move, she explained. "You have to throw yourself into problems. You have to sniff out what matters and what doesn't matter. You have to pin point what people's bottlenecks and pain points are and just start being useful," she said. Make decisions with less information than you think you need Bouzali referenced what Jeff Bezos once coined as his "70% rule." It argues that you should make decisions with 70% of the information, and Bouzali says it's something she tries to live by. "In certain domains, if you wait for 80% or 90% of the information, the opportunity will be gone," she said. It's a mantra she thinks more industry upstarts should adopt. "I sense that young people — and generally all people — overthink, overplan, and wait too long to curate the perfect path forward," she said. "Many decisions can be reversed, few decisions are irreversible." Chase impact rather than promotions No one — not even the best investors in the world — can predict the future. Bouzali knows this and suggests young people learn to focus on what's in front of them. "Don't obsess over the next 10 years," she said. "Just focus on winning the next 6 to 12 months." Getting things done versus chasing titles will naturally lead you to the next big thing. "Promotions don't follow ambition. They follow impact," Bouzali said. "A better question than 'How do I get ahead?' is 'What are the hard things that need to get done that I could do?'" Learn to slow down Bouzali's job demands she stay up to speed on the news and market at all times, so she uses reading as a way to diversify her perspectives outside the here and now. From obscure medieval history to art criticism and strange fiction, she prefers to read things "off the beaten path." "I try to avoid the super contemporary and super trendy because I really want to develop completely different mental threads," said Bouzali of her book choices. "It's been very good for me to just step completely outside of what is trendy here and now and find older, slower modes of thought." Read the original article on Business Insider
Bloomberg
6 minutes ago
- Bloomberg
Munich Re Posts €2.1 Billion Profit on ‘Very Low' Major Losses
By Munich Re said second-quarter profit rose as some major-loss expenditures were less than expected, prompting the German reinsurance company to confirm its full-year profit guidance. Preliminary profit in the three months through June increased to about €2.1 billion ($2.5 billion), the company said on Monday. It posted net income of €1.6 billion a year earlier.
